arrow
A

Alessandra Magnani

universite paris cite
H指数:20
被引数:2,856

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Orchestration of human multi-lineage hematopoietic cell development by humanized in vivo bone marrow models

人源化体内骨髓模型对人类多谱系造血细胞发育的调控

2025-04-220
OAAI
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell disease

严重炎症和谱系偏移与 sickle cell disease 患者中工程化造血干细胞的植入不良相关。

2025-04-010
OA
Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients
2023-06-016
OAAI
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy
2023-02-019
OAAI
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome (Aug, 10.1038/s41591-021-01641-x, 2022)
2022-08-090
OAAI
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
2022-01-2463
PRE
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome
2022-01-2467
OAAI
Retrieval of vector integration sites from cell-free DNA
2021-06-1728
PREAI
Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy
2019-09-1924
OAAI
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
2019-04-2448
OAAI
Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency
2019-01-2511
OAAI
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

输血依赖性 β-地中海贫血患者的基因治疗

2018-04-19539
OAAI
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
2018-02-2291
OAAI
Gene Therapy in a Patient with Sickle Cell Disease

镰状细胞病患者的基因治疗

2017-03-02559
OAAI
Mixed Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation in Sickle Cell Disease: Preliminary Results on Peripheral Blood Sorted Subpopulations and Erythroid Progenitors
2016-05-010
OAAI